VistaGen Announces Positive Preclinical Data Supporting AV-101's Potential for Treating Neuropathic Pain Comparable to Pregabalin (Lyrica(R)), without its Side Effects

Stock Information for VistaGen Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.